Abstract
High strength NH3–N in the effluent is the major issue in the pharmaceutical industry. A novel mariner-transposan based system could be the better solution for the treatment of high strength NH3–N in the pharmaceutical effluent.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
